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Available online xxxxImmunoassays using magnetic nanoparticles (MNP) are generally performed under the control of permanent
magnet close to themicro-tube of reaction. Using amagnet gives a powerfulmethod for drivingMNPbut remains
unreliable or insufﬁcient for a fully integrated immunoassay on lab-on-chip. The aim of this study is to develop a
novel lab-on-chip concept for high efﬁcient immunoassays to detect ovalbumin (Biodefense model molecule)
with microcoils employed for trapping MNP during the biofunctionalization steps. The objectives are essentially
to optimize their efﬁciency for biological recognition by assuring a better bioactivity (antibodies-ovalbumin), and
detect small concentrations of the targeted protein (~10 pg/mL). In this work, we studied the response of immu-
noassays complex function of ovalbumin concentration. The impact of MNP diameter in the biografting protocol
was studied and permitted to choose a convenient MNP size for efﬁcient biorecognition. We realized different
immunoassays by controlling MNP in test tube and in microﬂuidic device using a permanent magnet. The com-
parison between these two experiments allows us to highlight an improvement of the limit of detection in
microﬂuidic conditions by controlling MNP trapping with a magnet.
© 2016 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).Keywords:
Bacteria
Lab-on-chip
ELISA
Magnetic nanoparticles
Ovalbumin
Microcoils
Fluorescent microscopy1. Introduction
Biosensors could be deﬁned by the need to incorporate a biological,
biologically derived or biomimetic recognition elementwith a transduc-
ing element [1]. In a simpleway a biological response has to be detected
by a tool and converted in one way or another into an electrical signal.
Since the ﬁrst publication of Enzyme-Linked Immune-Sorbent Assay
(ELISA) by R. S. Yalow in 1960 [2], the ELISAmethod has been used as a
diagnostic tool in biology and medicine and it became one of the most
speciﬁc method in immunoassay for Alzheimer diseases [3], HIV virus
detection [4] or cancerous biomarker [5,6]. Particularly this technic al-
lows a detection of low concentration. Conventionally ELISA method is
performed in wells or tube. Three type of ELISA can be found direct
ELISA, sandwich ELISA and competitive ELISA but a prepared surface is
needed for all.
Another complementary method to ELISA has emerged using mag-
netic nano or micro beads [7] which are functionalized in ﬂuidic condi-
tions [8]. Since few years, the use of functionalized beads by trapping
them in a magnetic ﬁeld had opened the route to on-chip bead-based
ELISA system. In fact, a higher sensitivity is obtained using micro-nano
beads to increase surface to volume ratio combined with microﬂuidic
devices [9,10].).
. This is an open access article under
tegration of microcoils for on
/dx.doi.org/10.1016/j.sbsr.201Using MNP is a common way to realize immunoassay [11–14]. In
this topic, MNP have really interesting properties such as (i) speciﬁc
functionalization, (ii) easy manipulation, (iii) an important speciﬁc
surface (surface/volume ratio) which offers us a better condition for
biografting [15]. MNP are useful to realize an immunoassay on chip
[12,16], by blocking them with magnetic ﬁeld and injecting continuous
ﬂowwith different solutions [9]. Another alternative consists onmoving
nano-beads through different solutionswhich permit to realize dynam-
ic immunoassay [17].
Microﬂuidic devices are largely developed, in different domains, for
instance (i) quantiﬁcation [18,19] (ii) cell analysis [7,20]. Many
functions such as sensing, mixing, manipulation [21–23], could be inte-
grated on microﬂuidic devices with one aim to build a lab-on-chip
environment. Microﬂuidic device can be made of PDMS (PolyDimethyl
Siloxane). It is a silicone elastomer with desirable properties that
make it attractive for microﬂuidic components and biomedical applica-
tion. In fact, PDMS ensures thermal stability, permeability to gases,
easiness for handling and manipulating [24]. These properties allow a
rapid and low cost fabrication of microﬂuidic devices.
Nowadays ELISA using nanoparticles to detect pathogen bacteria
[25] is extensively applied for food poisoning [26,27] since it was con-
sidered as a major health threat by governments and other applications
are also pursued [28–30]. This speciﬁc ELISAmethod demonstrates that
a very low limit of detection could be reached with a high level of
sensitivity.the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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system in order to validate the concept of immunoassay formation
and MNP trapping and detection by microcoils. In fact, in this paper
we present one part of ourwork concerning the integration of immuno-
assay in microﬂuidic system which involves permanent magnet for
MNP capture. The next step will be to implementmicrocoils of trapping
and detection in a conveniently designed lab-on-chip.
2. Principle of magnetic trapping
MNP can be manipulated and controlled in ﬂuidic device by a mag-
netic ﬁeld created by a magnet or microcoils for instance [31–33].
As it known, when a particle is localized in a magnetic ﬁeld Ha
!
, it
obtains a magnetic moment aligned in the magnetic ﬁeld direction:
Mp
! ¼ χ Ha! ð1Þ
Mp
!
as magnetic susceptibility and χ as magnetic moment per volume
unit. We can distinguish two types of susceptibility: (i) intrinsic mag-
netic susceptibility χpwhich is the ratio of themagnetization to the ap-
pliedﬁeld (ii)measuredmagnetic susceptibility χmwhich is the ratio of
themagnetization to the local magnetic ﬁeld inside the particle. Besides
an equivalent bipolar moment Mp
!
is usually obtained to calculate the
magnetic force:
mp
! ¼ 3χp χm þ 1ð Þ
χp−χm
 
þ 3 χm þ 1ð Þ
h i Ha!: ð2Þ
Magnetic ﬁeld creates magnetic force to control MNP. Magnetic
force can be described as:
Fmp
! ¼ m!:∇!
 
: B
! ð3Þ
m! as the equivalent dipolar magnetic moment of each particles. When
magnetic particles are suspended in a ﬂuid, where μf is the permeability,
the relation between B
!
and Ha
!
can be described as:
B
!¼ μ f Ha
! ð4Þ
If we assumed that themagnetization is linear, and according to Eqs.
(2) and (4) the magnetic force acting on magnetic particle can be
described as:
Fmp
! ¼ μ f Vp
3 χp−χm
 
χp−χm
 
þ 3 χm þ 1ð Þ
h i Ha!:∇
 
Ha
! ð5Þ
Vp as the volume of a particle. We can extract from Eq. (5) two cases:
χpNχm where the particles will be under an attractive force and
χpbχm where the particles will be under a repulsive force. Magnetic
force can be used to attract and repulse magnetic particles and the
strong of the force depend of several parameters including magnetic
ﬁeld and parameters of the particle.
Regarding this consideration, simulations have been performed on
ANSYS® software to deﬁne the convenient design of microcoils for
efﬁcient MNP trapping. Indeed, in this paper we present microcoils
with the following optimized parameters: 45 turns, width of Copper
wires = 10 μm, distance between wires = 10 μm, height of wire =
10 μm, outer radius of the coil = 5 mm (Fig. 3).Please cite this article as: O. Lefebvre, et al., Integration of microcoils for on
ing and Bio-Sensing Research (2016), http://dx.doi.org/10.1016/j.sbsr.2013. Principle of immunoassay sandwich involving magnetic
nanoparticles
The enzyme-linked immunosorbent assay (ELISA) is a test that uses
antibodies to detect the presence of a substance (target), usually a bio-
marker, in a liquid sample or wet sample.
Ovalbumin is used as a model molecule for biodefense and as target
for the developed ELISA protocol in this work. The principle is to encap-
sulate the target (a biomarker) between two antibodies and one anti-
body for the detection. Primary antibody recognises a part (epitope)
of the biomarker, the second antibody recognises another epitope of
the biomarker. The detection antibody recognises a part of the second
antibody and the resulting structure forms the biological complex (im-
munoassay sandwich, Fig. 1b). This complex is completed by amagnetic
nanoparticle where the primary antibody is grafted with an EDC/NHS
protocol at 4 °C, Fig. 1a.
In addition, BSA is used to avoid the non-speciﬁc absorption of bio-
logical elements, this step is performed after the primary antibodies
grafting to ﬁll up free surface between antibodies. As it shows in Fig.
1c, a monolayer of antibodies could be grafted on one magnetic nano-
particle therefore several biological complex could be observed.
4. Material and methods
4.1. Material and experimental equipment
A microﬂuidic platform is used to perform immunoassay according
an ELISA protocol. A ﬂuidic pump and a syringe are used to inject ﬂuid
inside the microﬂuidic system. A Peltier module with an electrical
equipment and a temperature sensor are used to regulate the tempera-
ture during experiments. A ﬂuorescent microscope (Euromex Série B)
with 4x NeoLED™ for monochromatic LED Epi-Fluorescence and stan-
dard ﬁlters (Green EX 460–550 nm EM 590 nm) is used to visualize
ﬂuorescent antibodies.
The microfabrication of microﬂuidic devices and microcoils are
made in a clean room. Two types of 4 in. wafers are used, silicon wafer
and glass wafer.
Different equipment are used for microfabrication: UV-photolithog-
raphy EVG 620 for print panel on photoresist. Electrolyte bath using
Cu2SO4 and H2SO4 with integrated electrode of copper for electrodepo-
sition of copper. Denton sputtering system (EXPLORER Denton
Vacuum® system) and PECVD (STS PECVD System) for depositing
layer. Reactive Ion Etching (STS RIE system) and Ion Beam Etching
(IBE Roth & Rau IonSys 500) for etching layer. DEKTAK 8 (Veeco) and
Keyence microscope for characterization.
MNP with carboxylic terminal group are purchased from Adamtech
© (Carboxyl-Adembeads and MasterBeads Carboxylic Acid) and are
cleaned with NaOH 1 mM solution for one day.
Biological and chemical material are used in ELISA protocol:
EDC/NHS (N-(3-Dimethylaminopropyl)-N′-ethylcarbodiimide/N-
hydroxysulfosuccinimide from Sigma-Aldrich ©) for grafting. Primary
antibodies: Rabbit Anti-Ovalbumin (Hen White) from Merck Millipore
©. BSA (Bovine Serum Albumin) from Sigma-Aldrich © for passivation.
Ovalbumin (Albumin from chicken egg white) from Sigma-Aldrich ©.
Secondary antibodies: Puriﬁed anti-chicken ovalbumin from BioLegend
©. Detection antibodies: Anti-mouse IgG (Fab speciﬁc)-FITC antibody
produced in goat from Sigma-Aldrich ©. PEO solution (Poly(ethylene
oxide) from Sigma-Aldrich ©).
4.2. Microfabrication
4.2.1. Microﬂuidic on glass wafer
Microﬂuidic devices are composed of two parts: glass wafer with a
thin layer of PDMS (20 μm) spin-coated on it and ﬂuidic channels
made of PDMS. A schematic illustration of the process is presented in
Fig. 2a.-chip immunosensors based onmagnetic nanoparticles capture, Sens-
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Fig. 1. (a) EDC/NHS grafting protocol; schema of (b) one grafted immunocomplex; (c) magnetic nanoparticle with a layer of grafted immunocomplex.
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system. A 50 μm layer of SU8 2050 is spin coated on a clean silicon
wafer (Fig. 2a.2). A step of UV-photolithography is realized to obtain
the channel form (Fig. 2a.3). UV-photolithography conditions were
soft-contact and an energy of 250–260mJ/cm2. The height of themaster
mold is systematically veriﬁed using a mechanical proﬁlometer
(DEKTAK). The fabricated channel has systematically 50 μm of height
and 500 μm of wide.
PDMS is formed by the mixture of two solutions: silicon elastomer
and curing agent. We optimized the properties of the PDMS structured
whichwill ensure the best robustness of the ﬂuidic system. In this optic,
we used a standard ratio 10 (silicon elastomer) per 1 (curing agent).
PDMS is poured on the master mold and baked 2 h at 75 °C in an oven
to obtain a replica (Fig. 2a.4). The replica is unmold and inlet and outlet
aremade (Fig. 2a.5). The PDMS replica is bonded by anO2 plasma on theFig. 2. (a) Illustration: microfabrication steps of microﬂu
Please cite this article as: O. Lefebvre, et al., Integration of microcoils for on
ing and Bio-Sensing Research (2016), http://dx.doi.org/10.1016/j.sbsr.201prepared glass wafer (Fig. 2a.6 & 7 & b). Bonding conditions were a
power of 160Wwith a pressure of O2 at 0.4mbar and oneminute time.
Microﬂuidic system on silicon wafer.
In silicon wafer, twenty microcoils are fabricated in a clean room
using a mastered process [34], a schematic illustration of the process
is presented in Fig. 3a.
First, thewafer is clean by Piranha (mix of sulfuric acid andhydrogen
peroxide) and BHF (Buffer HF) solution (Fig. 3a.1). Then a thin layer
(200 nm) of silicate is deposited using an oxidation oven (Fig. 3a.2). A
seed layer of 100 nm of copper and 10 nm of titanium is added using
a cathode pulverization (Fig. 3a.3), conditions are for Titanium layer:
current of 200 mA for 600 s and then current of 276 V and a pressure
of 8 μbar for 200 s; for the copper layer: current of 400 mA for 200 s
and then current of 335 V and a pressure of 8 μbar for 200 s. A step of
UV-photolithography is made using an AZ4562 photoresist (Fig. 3a.4 &idic device; (b) photography of microﬂuidic device.
-chip immunosensors based onmagnetic nanoparticles capture, Sens-
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Fig. 3. (a) Summary ofmicrofabrication steps ofmicrocoils; (b) photography of onemicrocoil; (c) schematic viewofmicrocoils N: 45 turns,w:width ofwires=10 μm, s: distance between
wires = 10 μm, Rex: outer radius of the coil = 5 mm, Rin: inner radius of the coil = 3 mm.
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trodeposited a 10 μm layer of copper using a speciﬁc bathwith integrat-
ed electrodes (Fig. 3a.6) and we etched the sacriﬁcial layer (Fig. 3a.7).
We diced the wafer to separate microcoils (Fig. 3b).
Finally, to integratemicrocoil in themicroﬂuidic devicewe stick it on
a PCB board and a wire-bonding is done using an aluminium wire. An
electrical connection is realized to connectmicrocoil to an input current.
Microcoils are recovered with a 10 μm PDMS layer (proportion 2.5:1,
optimized for convenient soft covering of wires) to protect and to pre-
pare the O2 plasma bonding with the microﬂuidic channel part.4.3. ELISA protocol description
In test tube, an EDC/NHS protocol, 24 h at 4 °C, is performed to
grafted primary antibodies on MNP (Fig. 4b). BSA is added, to protect
MNP from non-speciﬁc absorption, during two hours at room tempera-
ture (Fig. 4c). Ovalbuminwhich is the target is added (different concen-
trations are tested) during two hours at room temperature (Fig. 4d).
Secondary antibodies are added during twohours (Fig. 4e) at room tem-
perature and ﬁnally detection antibodies are added during two hours at
room temperature (Fig. 4f). After each pre-deﬁned step a washing step,
using a magnet to block MNP, is done to remove all biological elementsFig. 4. (a–f) Schematic ELISA protocol; (g) protocol tim
Please cite this article as: O. Lefebvre, et al., Integration of microcoils for on
ing and Bio-Sensing Research (2016), http://dx.doi.org/10.1016/j.sbsr.201which are not grafted. Finally, the functionalized MNP are observed on
glass under the ﬂuorescent microscope.
In amicroﬂuidic system theELISAprotocol remainsmostly the same,
a step of channel protection is added and step times are reduced consid-
erably (Fig. 4g).
First PDMS channels are protected from unwanted absorption of
biological elements (antibodies, antigen) using an HCl/PEO protocol
(Fig. 5). After the O2 plasma (Fig. 5b) bonding the input and the output
of the microﬂuidic device are blocked to keep the activation. A 1 M HCl
solution is injected at 10 μL/min in order to protonating silanol groups
on PDMS surface (Fig. 5c & d), and then a PEO solution is injected to
graft PEO chains on PDMS surface (Fig. 5e & f). After cleaning the device
with PBS buffer, ELISA protocol as described previously is used. As ex-
pected, the step times are reduced, due to the conﬁnement of the reac-
tion on ﬂuidic condition. The EDC/NHS protocol decreased from 24 h to
30 min but remains at 4 °C using the temperature regulator. Next steps
are decreased from two hours to 10 min and we used the temperature
regulator to keep the temperature constant (22 °C to optimize the re-
producibility). Washing step can be realized at a more powerful ﬂow
rates, than biological step, regarding the ratio between the microﬂuidic
and the magnetic force. Finally the input and output are blocked to
avoid leaks of ﬂuids and then results are observed using a ﬂuorescent
microscope.e step of test in microtube and in ﬂuidic condition.
-chip immunosensors based onmagnetic nanoparticles capture, Sens-
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Fig. 5. Principles of covalent and adsorptive attachment of PEO. (a) Native surface of PDMS; (b) high density of silanol groups on the surface are produced by plasma treatment; (c–d)
silanol groups react with the terminal group of PEO; (e–f) physical and chemical absorption of PEO chains generates a polymer layer in PDMS surface.
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The ﬂuorescent characterization is carried out through the channels
of the microﬂuidic device. For one concentration of the target (ovalbu-
min) the experiment is realized several times (minimum 3 times). The
result is obtained by ﬂuorescent microscope imaging. Several images
are needed to observe all the detection area to validate that maximum
of complexes are characterized.
Each image is processed using a home-made developed program.
First a thresholding is applied for top and low values to avoid any
artefact. The background noises are deleted using the comparison of
an experiment without ovalbumin (control experiment). Too big lumi-
nescent responses related to the aggregations of MNP or antibodies are
eliminated. Finally the intensity of one image Iimage is extracted. For one
channel the intensity calculated Ichannel is the average of the intensities
(Iimage) of each image from the channel. And for one concentration of
the ovalbumin the intensity calculated Iconcentration is the average of
the Ichannel of the same concentration.Fig. 6. (a)Whole biografting process is respected; we skipped (b) the primary antibody grafting
without PDMS protection by HCl/PEO.
Please cite this article as: O. Lefebvre, et al., Integration of microcoils for on
ing and Bio-Sensing Research (2016), http://dx.doi.org/10.1016/j.sbsr.2015. Results and discussion
5.1. Immunoassay complex validation
The ﬁrst investigation concerns the grafting step of the antibody
layer on the biological process. We need to demonstrate that if we
skip a step (EDC/NHS protocol step, the ovalbumin step and the de-
tection antibody step) on the protocol, the complex formation is
not validated in ﬁnal. These experiments were realized in tube and
in themicroﬂuidic device. Images presented in this paper were extract-
ed from experiments in microﬂuidic device. We can see a successful
immunoassay (Fig. 6a) and unsuccessful immunoassays (Fig. 6b–d).
A study on the protection of PDMS from aggregation of biological el-
ement was realized by removing the HCl/PEO protocol, the results
with the emergence of aggregation phenomena are presented in
Fig. 6e.
In conclusion we demonstrate that without primary antibody (Fig.
6b), ovalbumin (Fig. 6c) or detection antibody (Fig. 6d), immunoassaystep; (c) the ovalbumin grafting step; (d) the detection antibody grafting step; € channel
-chip immunosensors based onmagnetic nanoparticles capture, Sens-
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Fig. 7. Intensity of the response of immunoassay extracted from test using different size of
magnetic nanoparticles.
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and antibodies were appearing.
5.2. Inﬂuence of magnetic nanoparticles diameter
The second study concerns the inﬂuence of the MNP diameter. We
showed in part 2 that the magnetic force is depending of the magnetic
ﬁeld and MNP properties. In fact if we decrease the size of the MNP
we need to increase the magnetic ﬁeld to have a constant magnetic
force. In the other hand MNP have a behavior that follows speciﬁc sur-
face formulas (6), (7) and (8). In particular, we can conclude that the
speciﬁc surface decreases with the diameter of the MNP.
è
è
Vsph re ¼
4πR3
3
ð6Þ
Asph re ¼ 4πR2 ð7Þ
χA=V ¼
3
R
ð8Þ
In this optic, we performed experiments with MNP of 200 nm,
300 nm and 500 nm diameter. For each experiment we use the same
volume of MNP (10 μL) and all the step remain the same. The results
in Fig. 7, conﬁrm the dependence of the grafting on the speciﬁc surface.
In other hand, to limit the thermal Joule effectwhenwe inject current in
microcoils of trapping of MNPwe need to avoid a very low size of nano-
particles which required a very high magnetic ﬁeld to control them. In-
deed, we eliminated the size of 200 nm and a diameter of 300 nm wasFig. 8. Fluorescent intensity of immunoassay response function of ovalb
Please cite this article as: O. Lefebvre, et al., Integration of microcoils for on
ing and Bio-Sensing Research (2016), http://dx.doi.org/10.1016/j.sbsr.201selected regarding the magnetic force needed and the intensity
detected.
5.3. Inﬂuence of ovalbumin concentration immunoassay response function
The ﬁnal study presented in this paper concerns the immunoassay
response, involving the 300 nmMNP, function of ovalbumin concentra-
tion. It should give us information about the limit of detection (L.O.D)
that can be reached. The L.O.D. is determined using the formula:
L:O:D: ¼ I0 þ 3  σD ð4Þ
σD: standard deviation and I0: intensity with no target. Our aim is to
obtain the minimum intensity detectable which permit us to access
to ovalbumin concentration that we can detect. The ﬁrst analysis con-
cerns the test in microtubes which are easier to manipulate then in
microﬂuidic device with a permanent magnet.
We realized immunoassay usingprotocol in test tube as describe in 3
and we varied the concentration of ovalbumin from 0 μM to 15 μM
(Fig. 8a). The curve shows us two parts: the ﬁrst from 0 to 4 μmwhich
corresponds to the enhancement of the biological complex quantity
developed on the surface of MNP. The second one from 4 to 15 μM
corresponds to a plateau when all or most bioactive sites have been
occupied by a biological complex. The L.O.D. obtained by the formula
(4) is 1.2 nM.
As inmicrotubes we followed the same protocol for microﬂuidic de-
vice as described in the part Section 4.3. We used a permanent magnet
below the microﬂuidic channels to control MNP. We also realized the
experiments for the same concentrations of ovalbumin (Fig. 8b) to
compare the two ELISA environments of experimentation (inmicrotube
and microﬂuidic conditions). As described in the part Section 3, the
microﬂuidic device allows us not only to save considerably the time re-
action but also to reach a better L.O.D. close to 0.3 nM.
In conclusion an improved limit of detectionwas conﬁrmed (divided
by 4) for integrated immunoassay of ovalbumin detection compared to
those in microtube environment, essentially by controlling the MNP
trapping with a magnet in microﬂuidic conditions.
6. Conclusion
We developed an original and innovative fully-integrated immuno-
assay on lab-on-chip in order to detect bacteria. We use ovalbumin as a
Biodefense model biomarker, magnetic nanoparticles and ELISA proto-
col to perform immunoassay. We demonstrate the advantage of
microﬂuidic environment by reducing grafting and preparation time
and optimizing the limit of detection (less four times than microtube
test).
By introducing microcoils in ﬂuidic condition, we hope to obtain a
fully integrated lab-on-chip which should allow us to attain optimalumin concentration: (a) in microtubes; (b) in microﬂuidic devices.
-chip immunosensors based onmagnetic nanoparticles capture, Sens-
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tration for biodefense applications.
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